Waldencast plc (WALD)
- Previous Close
3.3800 - Open
3.4000 - Bid 3.4000 x 100
- Ask 3.4500 x 100
- Day's Range
3.3853 - 3.5800 - 52 Week Range
2.4050 - 12.0000 - Volume
4,456 - Avg. Volume
240,770 - Market Cap (intraday)
444.265M - Beta (5Y Monthly) -0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.7400 - Earnings Date Nov 20, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.75
Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.
www.waldencast.com284
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WALD
View MorePerformance Overview: WALD
Trailing total returns as of 10/8/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WALD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WALD
View MoreValuation Measures
Market Cap
414.60M
Enterprise Value
583.40M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.43
Price/Book (mrq)
0.67
Enterprise Value/Revenue
2.43
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-29.39%
Return on Assets (ttm)
-4.42%
Return on Equity (ttm)
-10.74%
Revenue (ttm)
240.38M
Net Income Avi to Common (ttm)
-70.64M
Diluted EPS (ttm)
-0.7400
Balance Sheet and Cash Flow
Total Cash (mrq)
19.69M
Total Debt/Equity (mrq)
24.79%
Levered Free Cash Flow (ttm)
8.76M
Research Analysis: WALD
View MoreCompany Insights: WALD
WALD does not have Company Insights